New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|November 29, 2013
Supplements and Featured Publications
- A Data-Driven Approach to Improving Clinical and Economic Outcomes in Multiple Sclerosis [CME/CNE/CP
- Volume 19
- Issue 16 Suppl
Post Test: A Data-Driven Approach to Improving Clinical and Economic Outcomes in Multiple Sclerosis
Advertisement
Instructions
After reading “A Data-Driven Approach to Improving Clinical and Economic Outcomes in Multiple Sclerosis,” complete the program evaluation and select the single best answer to each of the posttest questions.
Participants must read each article in this supplement, complete the online posttest achieving a passing score of 70% or higher, and complete an online evaluation and request for credit. Detailed instructions on obtaining CE credit are included following the sample online posttest.
Articles in this issue
almost 13 years ago
Managed Care Aspects of Managing Multiple Sclerosisalmost 13 years ago
Management of Multiple Sclerosisalmost 13 years ago
Multiple Sclerosis UpdateAdvertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Roundtables reveal HFpEF/HFmrEF care lags despite rising cases; learn new SGLT2/MRA strategies, screening, and scalable team pathways.
Simple operational changes are proving more effective at closing gaps in cardiovascular-kidney-metabolic (CKM) syndrome care than education campaigns alone, according to panelists at at Population Health Roundtable
Panelists at AJMC roundtables in Philadelphia, Boston, Washington, DC, and Chicago traced why atopic dermatitis stays undertreated despite new therapies.
Eye care access for underserved patients with diabetes is limited and poorly understood. We identified barriers and innovative solutions to improve overall care and establish evidence-based practices.
Patient understanding should be treated as a measurable equity outcome, not an assumed byproduct of care.
The Right Care Initiative provides a proven, scalable framework for reducing preventable cardiovascular deaths. By integrating interorganizational learning, pharmacist-led care, and precision screening (coronary artery calcium imaging), the model bridges the 17-year implementation gap between clinical evidence and improved population health.
Advertisement
Advertisement
Trending on AJMC
1
Delayed Dupilumab Raises Asthma Costs 32%: Nicola Hanania, MD
2
Across the US, Obesity Care Still Lacks an Owner
3
FDA Expands Finerenone Approval to CKD Associated With Type 1 Diabetes
4
Aspirin's CRC Benefit Narrows to PIK3CA Exon 9/20 Mutations
5